| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |